STOCKHOLM, July 11, 2022 /PRNewswire/ — Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQÂ Stockholm: CALTX) (“Calliditas”) today announced that the company has added two members to its management team, Head of Human…
- Saturday, September 30, 2023
STOCKHOLM, July 11, 2022 /PRNewswire/ — Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQÂ Stockholm: CALTX) (“Calliditas”) today announced that the company has added two members to its management team, Head of Human…